EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genodermatoses: Current Strategies for Disease Modeling and Prospects

A. S. Ponomarev, R. R. Norkin, L. A. Khusainova, L. M. Yanygina, M. D. Drugova, V. V. Solovyeva, A. A. Rizvanov

Applied Biosciences · 06.11.2026 · 5 (4) · 113

DOI: 10.3390/applbiosci5040113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biosciences, online erschienen am 06.11.2026. Verfasst von A. S. Ponomarev und 6 weiteren Autor:innen. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kazan Federal University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genodermatoses are rare hereditary skin disorders, most of which still lack effective curative treatment, and progress toward modern therapy depends on experimental models that capture both the genetic defect and its tissue context. This review examines the main modeling platforms (patient-derived induced pluripotent stem cells (iPSC), 3D organotypic skin equivalents, and animal models), with emphasis on ichthyoses and epidermolysis bullosa, and considers their role in the development of gene therapy and genome editing, as well as patent activity in the field. The platforms are not hierarchical; they differ in how they balance genetic fidelity against physiological context and are best viewed as complementary. Common limitations include reliance on qualitative readouts and the lack of developmental and chronic dimensions, which restricts how well the models reproduce lifelong diseases with graded severity. Translational barriers include the high cost and limited scalability of clinical-grade iPSC products, reliance on individually prepared patient material, small patient cohorts, and the absence of qualified genodermatosis-specific endpoints. Emerging technologies, such as skin-on-chip systems, spatial omics, and base/prime editing, could help address some of these gaps. This review outlines how common quantitative criteria, shared reference material, and agreed qualification pathways could make existing models comparable and link them to therapeutic development.

Förderung

  • Kazan Federal University

Zitieren

APA

Ponomarev, A. S., Norkin, R. R., Khusainova, L. A., Yanygina, L. M., Drugova, M. D., Solovyeva, V. V., & Rizvanov, A. A. (2026). Genodermatoses: Current Strategies for Disease Modeling and Prospects. Applied Biosciences, 5(4), 113. https://doi.org/10.3390/applbiosci5040113

Vancouver

Ponomarev AS, Norkin RR, Khusainova LA, Yanygina LM, Drugova MD, Solovyeva VV, et al. Genodermatoses: Current Strategies for Disease Modeling and Prospects. Applied Biosciences. 2026;5(4):113. doi:10.3390/applbiosci5040113

BibTeX
@article{Ponomarev2026,
  author = {Ponomarev, A. S. and Norkin, R. R. and Khusainova, L. A. and Yanygina, L. M. and Drugova, M. D. and Solovyeva, V. V. and Rizvanov, A. A.},
  title = {Genodermatoses: Current Strategies for Disease Modeling and Prospects},
  journal = {Applied Biosciences},
  year = {2026},
  volume = {5},
  number = {4},
  pages = {113},
  doi = {10.3390/applbiosci5040113}
}
Kostenlos starten →